Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma

NCT04910022 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma
Diffuse Glioma

Interventions

DRUG: NMS-03305293
DRUG: Temozolomide

Sponsor

Nerviano Medical Sciences